The DOI matches its Crossref record; 228 of the 228 references it cites were found in a registry or an index.
Metabolic disturbances in non-alcoholic fatty liver disease
Abstract
NAFLD (non-alcoholic fatty liver disease) refers to a wide spectrum of liver damage, ranging from simple steatosis to NASH (non-alcoholic steatohepatitis), advanced fibrosis and cirrhosis. NAFLD is strongly associated with insulin resistance and is defined by accumulation of liver fat >5% per liver weight in the presence of <10 g of daily alcohol consumption. The exact prevalence of NAFLD is uncertain because of the absence of simple non-invasive diagnostic tests to facilitate an estimate of prevalence. In certain subgroups of patients, such as those with Type 2 diabetes, the prevalence of NAFLD, defined by ultrasound, may be as high as 70%. NASH is an important subgroup within the spectrum of NAFLD that progresses over time with worsening fibrosis and cirrhosis, and is associated with increased risk for cardiovascular disease. It is, therefore, important to understand the pathogenesis of NASH and, in particular, to develop strategies for interventions to treat this condition. Currently, the ‘gold standard’ for the diagnosis of NASH is liver biopsy, and the need to undertake a biopsy has impeded research in subjects in this field. Limited results suggest that the prevalence of NASH could be as high as 11% in the general population, suggesting there is a worsening future public health problem in this field of medicine. With a burgeoning epidemic of diabetes in an aging population, it is likely that the prevalence of NASH will continue to increase over time as both factors are important risk factors for liver fibrosis. The purpose of this review is to: (i) briefly discuss the epidemiology of NAFLD to describe the magnitude of the future potential public health problem; and (ii) to discuss extra- and intra-hepatic mechanisms contributing to the pathogenesis of NAFLD, a better understanding of which may help in the development of novel treatments for this condition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–228 of 228
Yamaguchi, K., Yang, L., McCall, S. J., Huang, J., Yu, X. X., Pandey, S., Bhanot, S., Monia, B. P., Li, Y.-X., & Diehl, A. M. (2007) · Hepatology · doi:10.1002/hep.21988 · Cited by 103
MARCHAND‐BRUSTEL, Y. L., Gual, P., Grémeaux, T., Gonzalez, T., Barrès, R., & Tanti, J. (2003) · Biochemical Society Transactions · doi:10.1042/bst0311152 · Cited by 102
Holt, H., Wild, S. H., Wood, P. J., Zhang, J.-L., Darekar, A., Dewbury, K. C., Poole, R., Holt, R. I. G., Phillips, D. I., & Byrne, C. D. (2005) · Diabetologia · doi:10.1007/s00125-005-0070-x · Cited by 100
Self-citationZhang, Y., Yin, L., & Hillgartner, F. B. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m200283-jlr200 · Cited by 99
Non-alcoholic fatty liver disease in obese children evaluated by magnetic resonance imaging
Radetti, G., Kleon, W., Stuefer, J., & Pittschieler, K. (2006) · Acta Paediatrica · doi:10.1080/08035250500449890 · Cited by 95
PTEN and SHIP2 phosphoinositide phosphatases as negative regulators of insulin signalling
Vinciguerra, M., & Foti, M. (2006) · Archives of Physiology and Biochemistry · doi:10.1080/13813450600711359 · Cited by 92
Burdge, G. C., Lillycrop, K. A., Jackson, A. A., Gluckman, P. D., & Hanson, M. A. (2007) · British Journal Of Nutrition · doi:10.1017/s0007114507815819 · Cited by 91
Haukeland, J. W., Konopski, Z., Linnestad, P., Azimy, S., Løberg, E. M., Haaland, T., Birkeland, K. I., & Bjøro, K. (2005) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520500264953 · Cited by 89
Mordier, S., & Iynedjian, P. B. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.08.004 · Cited by 87
Choline Deficiency–Induced Liver Damage Is Reversible in Pemt−/− Mice
Waite, K. A., Cabilio, N. R., & Vance, D. E. (2002) · Journal of Nutrition · doi:10.1093/jn/132.1.68 · Cited by 83
Ahmed, M. H., & Byrne, C. D. (2005) · Wiley eBooks · doi:10.1002/0470025131.ch11 · Cited by 79
Self-citationWatanabe, S., Horie, Y., Kataoka, E., Sato, W., Dohmen, T., Ohshima, S., Goto, T., & Suzuki, A. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04665.x · Cited by 77
Ono, H., Katagiri, H., Funaki, M., Anai, M., Inukai, K., Fukushima, Y., Sakoda, H., Ogihara, T., Onishi, Y., Fujishiro, M., et al. (2001) · Molecular Endocrinology · doi:10.1210/mend.15.8.0684 · Cited by 77
Akbar, D. H., & Kawther, A. H. (2003) · Diabetes Care · doi:10.2337/diacare.26.12.3351-a · Cited by 75
Renier, G., Skamene, E., Sanctis, J. B. D., & Radzioch, D. (1993) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.13.2.190 · Cited by 74
Larter, C. Z., Yeh, M. M., Cheng, J., Williams, J., Brown, S., Dela Pena, A., Bell‐Anderson, K. S., & Farrell, G. C. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05157.x · Cited by 70
Effects of gastroplasty on body weight and related biological abnormalities in morbid obesity.
Luyckx, F., Scheen, A. J., Desaive, C., Dewé, W., Gielen, J.-L., & Lefebvre, P. J. (1998) · PubMed · Cited by 68
Burdge, G. C., Slater-Jefferies, J. L., Grant, R., Chung, W.-L., West, A. L., Lillycrop, K. A., Hanson, M. A., & Calder, P. C. (2008) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2007.10.028 · Cited by 61
Fukui, K., Wada, T., Kagawa, S., Nagira, K., Ikubo, M., Ishihara, H., Kobayashi, M., & Sasaoka, T. (2005) · Diabetes · doi:10.2337/diabetes.54.7.1958 · Cited by 59
Korsheninnikova, E., van der Zon, G. C. M., Voshol, P. J., Janssen, G. M. C., Havekes, L. M., Grefhorst, A., Kuipers, F., Reijngoud, D., Romijn, J. A., Ouwens, D. M., et al. (2006) · Diabetologia · doi:10.1007/s00125-006-0439-5 · Cited by 56
Zhang, J., Wang, C., Terroni, P. L., Cagampang, F. R. A., Hanson, M. A., & Byrne, C. D. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00351.2004 · Cited by 55
Self-citationHolt, H. B., Wild, S. H., Postle, A. D., Zhang, J., Koster, G., Umpleby, M., Shojaee-Moradie, F., Dewbury, K., Wood, P. J., Phillips, D. I., et al. (2007) · Diabetologia · doi:10.1007/s00125-007-0629-9 · Cited by 48
Self-citationIncrease of PTEN Gene Expression in Insulin Resistance
Lo, Y.-S., Tsao, C. J., Liu, I.-M., LIOU, S. ‐., & Cheng, J. (2004) · Hormone and Metabolic Research · doi:10.1055/s-2004-826016 · Cited by 42
Holt, H., Wild, S. H., Wareham, N. J., Ekelund, U., Umpleby, A. M., Shojaee‐Moradie, F., Holt, R. I. G., Phillips, D. I., & Byrne, C. D. (2007) · Diabetologia · doi:10.1007/s00125-007-0705-1 · Cited by 42
Self-citationPrevalence and Risk Factors of Diabetic Foot Problems in Taiwan
Tseng, C. (2003) · Diabetes Care · doi:10.2337/diacare.26.12.3351 · Cited by 41
Association Among C-Reactive Protein, Fatty Liver Disease, and Cardiovascular Risk
Lizardi-Cervera, J., Chávez-Tapia, N. C., Pérez-Bautista, O., Ramos, M. H., & Uribe, M. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9262-6 · Cited by 36
Nishimaki‐Mogami, T., Yao, Z., & Fujimori, K. (2002) · Journal of Lipid Research · doi:10.1194/jlr.m100354-jlr200 · Cited by 34
Ahmed, M. H. (2007) · American Journal of Clinical Pathology · doi:10.1309/jxwum661t8vt1etx · Cited by 33
Self-citation
Cited by
Health Implications of High Dietary Omega-6 Polyunsaturated Fatty Acids
Patterson, E., Wall, R., Fitzgerald, G. F., Ross, R. P., & Stanton, C. (2012) · Journal of Nutrition and Metabolism · doi:10.1155/2012/539426 · Cited by 883
Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace
Baffy, G., Brunt, E. M., & Caldwell, S. H. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.10.027 · Cited by 858
Plasma Metabolomic Profile in Nonalcoholic Fatty Liver Disease
Kalhan, S. C., Guo, L., Edmison, J., Dasarathy, S., McCullough, A. J., Hanson, R. W., & Milburn, M. (2011) · Metabolism · doi:10.1016/j.metabol.2010.03.006 · Cited by 532
Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?
Bhatia, L. S., Curzen, N. P., Calder, P. C., & Byrne, C. D. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehr453 · Cited by 496
Self-citationEpidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups
Lonardo, A., Bellentani, S., Argo, C. K., Ballestri, S., Byrne, C. D., Caldwell, S. H., Cortez-Pinto, H., Grieco, A., Machado, M. V., Miele, L., et al. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2015.08.004 · Cited by 444
Self-citation
Metadata
- Authors
- Byrne, C. D., Olufadi, R., Bruce, K. D., Cagampang, F. R., & Ahmed, M. H.
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 2009-03-02
- Volume
- 116
- Issue
- 7
- Pages
- 539-564
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- OpenAlex
- W2086431545
- Cited by
- 258
- References
- 228
- FWCI
- 16.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.